Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.14 million. The enterprise value is 1.76 million.
| Market Cap | 1.14M |
| Enterprise Value | 1.76M |
Important Dates
The last earnings date was Monday, September 29, 2025.
| Earnings Date | Sep 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has increased by 92.20% in one year.
| Current Share Class | 7.42M |
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | +92.20% |
| Shares Change (QoQ) | -47.65% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | n/a |
| Float | 6.81M |
Valuation Ratios
The trailing PE ratio is 78.13.
| PE Ratio | 78.13 |
| Forward PE | n/a |
| PS Ratio | 0.09 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | 3.03 |
| P/OCF Ratio | 3.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.40, with an EV/FCF ratio of 4.68.
| EV / Earnings | 62.80 |
| EV / Sales | 0.15 |
| EV / EBITDA | 3.40 |
| EV / EBIT | 13.24 |
| EV / FCF | 4.68 |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.72 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.01 |
| Debt / FCF | 1.39 |
| Interest Coverage | 5.87 |
Financial Efficiency
Return on equity (ROE) is 5.67% and return on invested capital (ROIC) is 3.49%.
| Return on Equity (ROE) | 5.67% |
| Return on Assets (ROA) | 1.71% |
| Return on Invested Capital (ROIC) | 3.49% |
| Return on Capital Employed (ROCE) | 5.77% |
| Revenue Per Employee | 308,876 |
| Profits Per Employee | 720 |
| Employee Count | 40 |
| Asset Turnover | 2.47 |
| Inventory Turnover | 3.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.41% in the last 52 weeks. The beta is 0.11, so Escalon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -1.41% |
| 50-Day Moving Average | 0.29 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 37.42 |
| Average Volume (20 Days) | 41,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.05 million and earned 28,094 in profits. Earnings per share was 0.00.
| Revenue | 12.05M |
| Gross Profit | 5.51M |
| Operating Income | 133,217 |
| Pretax Income | 105,525 |
| Net Income | 28,094 |
| EBITDA | 171,036 |
| EBIT | 133,217 |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 545,835 in cash and 523,303 in debt, giving a net cash position of 22,532 or 0.00 per share.
| Cash & Cash Equivalents | 545,835 |
| Total Debt | 523,303 |
| Net Cash | 22,532 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.92M |
| Book Value Per Share | 0.17 |
| Working Capital | 1.93M |
Cash Flow
In the last 12 months, operating cash flow was 380,725 and capital expenditures -3,880, giving a free cash flow of 376,845.
| Operating Cash Flow | 380,725 |
| Capital Expenditures | -3,880 |
| Free Cash Flow | 376,845 |
| FCF Per Share | 0.05 |
Margins
Gross margin is 45.75%, with operating and profit margins of 1.11% and 0.88%.
| Gross Margin | 45.75% |
| Operating Margin | 1.11% |
| Pretax Margin | 0.88% |
| Profit Margin | 0.88% |
| EBITDA Margin | 1.42% |
| EBIT Margin | 1.11% |
| FCF Margin | 3.13% |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -92.20% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.46% |
| FCF Yield | 33.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -15.92 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.92 |
| Piotroski F-Score | 8 |